Skip to main content
TFX
NYSE Industrial Applications And Services

Teleflex Locks In $250M Accelerated Buyback with Truist, Backed by OEM Sale Proceeds

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$134.98
Mkt Cap
$5.976B
52W Low
$100.18
52W High
$145
52W Position info
35% above low
Off High info
6.9% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

TFX sits 35% above its 52-week low of $100.18.

Summary

Teleflex entered into a $250 million accelerated share repurchase with Truist Bank, funded by its OEM sale proceeds, with initial delivery of 80% of the shares based on the August 6 closing price and final settlement by Q4 2026.


Key Events · Financing and Capital Events · TFX

  • $250M ASR Executed with Truist

    Teleflex entered into an accelerated share repurchase agreement with Truist Bank for $250 million of its common stock, part of the previously announced $1 billion buyback program.

  • Initial Delivery of 80% of Shares

    On August 10, 2026, Teleflex will pay $250 million and receive shares worth $200 million (80% of the repurchase price) based on the August 6 closing price, providing immediate share count reduction.

  • Final Settlement Tied to VWAP

    The total number of shares repurchased will be determined by volume-weighted average prices during the ASR term, less a discount, with potential for additional shares or a small cash payment at settlement.

  • Funding from OEM Divestiture Proceeds

    The repurchase is funded by proceeds from the $1.5 billion sale of the OEM business, which closed on August 3, 2026, directly returning capital to shareholders.


Analysis · TFX · Industrial Applications And Services

Teleflex has formalized the $250 million accelerated share repurchase announced yesterday alongside strong Q2 results, entering into an agreement with Truist Bank. Proceeds from the recently closed $1.5 billion OEM divestiture will fund the buyback, directly returning capital to shareholders. The initial delivery of shares—80% of the repurchase price based on the August 6 closing price—provides immediate accretion, while the final settlement tied to volume-weighted average prices could result in additional shares or a small cash payment. This execution demonstrates management's commitment to the $1 billion repurchase program and signals confidence in the company's post-divestiture valuation.

At the time of this filing, TFX was trading at $134.98 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $6B. The 52-week trading range was $100.18 to $145.00. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

TFX - Latest Insights

TFX
Aug 06, 2026, 3:08 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $138.74
Real-time Price: $134.98 info
Change: -$3.76 (-3%) info
Market Cap: $5.976B info
TFX
Aug 06, 2026, 7:08 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $136.78
Real-time Price: $134.98 info
Change: -$1.80 (-1%) info
Market Cap: $5.976B info
TFX
Aug 06, 2026, 6:46 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $136.78
Real-time Price: $134.98 info
Change: -$1.80 (-1%) info
Market Cap: $5.976B info
TFX
Aug 06, 2026, 6:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $136.78
Real-time Price: $134.98 info
Change: -$1.80 (-1%) info
Market Cap: $5.976B info
TFX
Aug 05, 2026, 4:44 PM EDT
Filing Type: 8-K/A
Importance Score:
7
Price at Filing: $136.78
Real-time Price: $134.98 info
Change: -$1.80 (-1%) info
Market Cap: $5.976B info